Tech Leaders’ Money in Biotech Reached Public Stocks First Through Acquisitions and Narratives: A Map of 94 Companies and a Review of U.S. and Korean Listed Companies
A Map of Biotech Investing: Where You Earn Only If the Drug Works, and Where You Earn Whichever Drug Works
